This article is a Preprint
Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.
The added value of chest high-resolution CT findings of Corona Virus Disease 2019 in predicting severity of disease (preprint)
researchsquare; 2020.
Preprint
in English
| PREPRINT-RESEARCHSQUARE | ID: ppzbmed-10.21203.rs.3.rs-17701.v1
ABSTRACT
The aim of this study was to retrospectively analyze chest thin-section high-resolution CT (HRCT) findings for 32 patients with Corona Virus Disease 2019 (COVID-19) and clarify the correlation between CT data and laboratory results. 30 patients presented with abnormal initial CT scans. Of 30 patients, COVID-19 showed the involvement of bilateral lungs in 24 (80%), involvement of more than two lobes in 24 (80%), ground-glass opacities without consolidation in 27 (90%), ground-glass opacities with consolidation in 23 (76.7%), opacities with irregular intralobular lines in 26 (86.7%), opacities with round morphology in 25 (83.3%), and peripheral distribution in 30 (100%). Pleural effusion or mediastinal lymphadenopathy was relatively rare manifestations. Rapidly progression of the disease demonstrated by increasing number and range of ground glass opacities and appearance of consolidations at follow-up CT images in two patients. The CT lung severity score and No. of lobes involved were negatively correlated with lymphocyte count(r=-0.363, P=0.041; r=-0.367, P=0.039, respectively). Chest HRCT of COVID-19 predominantly manifests multiple, round, ground glass opacities with irregular intralobular lines, and peripheral distribution of bilateral lungs. HRCT is a potential tool for early screening, assessing progress, and predicting disease severity of COVID-19.Authors Jie Zhou and Jie Cao contributed equally to this work and are co-first authors.
Full text:
Available
Collection:
Preprints
Database:
PREPRINT-RESEARCHSQUARE
Main subject:
Pleural Effusion
/
Virus Diseases
/
COVID-19
/
Lymphatic Diseases
Language:
English
Year:
2020
Document Type:
Preprint
Similar
MEDLINE
...
LILACS
LIS